The Lancet EDITORIAL| VOLUME 396, ISSUE 10263 , P1607, NOVEMBER 21, 2020 Excerpts The prospect of preventing illness and death, and avoiding the harm and misery of extended restrictions, is a cause for optimism. But although it is right to be hopeful and encouraged, we are far from ending COVID-19 as a public health issue. Pfizer and Moderna together project that there will be enough vaccine for 35 million individuals in 2020, and perhaps up to 1 billion in 2021. As a result, many millions...